Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trialJames O. Lindsay, John A. Snowden, Lizzie Swaby et al.|The Lancet. Gastroenterology & hepatology|2024Cited by 19